Discuss the timeline of the development of treatment options for pulmonary hypertension (PH) including recently approved and treatment options currently in clinical trials.
• Identify presentation and management of pulmonary hypertension in patients with sarcoidosis.
• Explain the current approach to pulmonary hypertension in the presence of Hereditary Hemorrhagic Telangiectasia (HHT

Join in the Third Annual Pulmonary Hypertension CME Conference, which will be held on Sep 27, 2024, and earn 6.75 CME Credits, Intended for Pulmonologists.
Explain Shared Decision making in the management of PH
• Describe the use of Balloon Pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
• Discuss the care of the critically ill PH patient.
• Describe the use of extramembrane corporeal membrane oxygenation (ECMO) in PH patients. •